-
Delayed Access to Diabetes Technology in Children With Migration Background: A Cross-Sectional Study on Treatment Equity in Austria
Sep 9, 2025, 16:22 PM -
Overfitting Mitigation in Neural Networks: Could Ergodic Regularization Be the Future of AI?
Sep 9, 2025, 16:22 PM -
Cost of Illness Study: Cushing's Syndrome in the Kingdom of Saudi Arabia
Sep 9, 2025, 16:22 PM -
Reliability Test of the Hungarian Versions of the Hypertension Knowledge Test and the QLICD-HY Quality of Life Assessment Questionnaire Among People With High Blood Pressure
Sep 9, 2025, 16:22 PM -
Expert Consensus on a Definition for Children With Medical Complexity in England: A Modified Delphi Panel
Sep 9, 2025, 16:22 PM -
Health Equity Considerations in Economic Evaluation: Comparative Acceptability and Application Across European HTA Bodies
Sep 9, 2025, 16:22 PM -
Tocilizumab vs. Sarilumab Among Adults Hospitalized Due to COVID-19: A Federated Comparative Effectiveness Study Across England and Scotland Under the Target Trial Emulation Framework
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of Image-Guided Ablation vs. Conventional Ablation in Patients With Recurrent Ventricular Tachycardia: Results From the inEurHeart Trial
Sep 9, 2025, 16:22 PM -
Inequity in Public Healthcare Utilization Among Persons With Disabilities in Bangladesh: A Benefit Incidence Analysis
Sep 9, 2025, 16:22 PM -
Beyond the Mean: Do Distribution-Based Metrics Offer Greater Insight Into Predictors of Societal Health Preferences? A Secondary Analysis of 42 EQ-5D-5L Value Sets
Sep 9, 2025, 16:22 PM -
The Clinical Impact of Screening Blood Donations for Hepatitis E Virus in Catalonia
Sep 9, 2025, 16:22 PM -
Advancing Real-World Evidence in Diffuse Large B-cell Lymphoma: Insights From EHR-Derived Data in the UK
Sep 9, 2025, 16:22 PM -
AI-Driven Simulation of FDA DCOA Review to Inform Evidence Planning and Regulatory Strategy
Sep 9, 2025, 16:22 PM -
Impact of CIDP on Health-Related Quality of Life Fatigue and Daily Activities: Results From a Real-World International Survey
Sep 9, 2025, 16:22 PM -
The Long-Term Cost-Effectiveness of Insulin Icodec vs. Once-Daily Basal Insulin Analogs in Italy
Sep 9, 2025, 16:22 PM -
German Early Benefit Assessments and the Impact of Medical Societies: An Analysis
Sep 9, 2025, 16:22 PM -
Economic and Organizational Impact of Subcutaneous Ocrelizumab in French Daily Hospitals
Sep 9, 2025, 16:22 PM -
Burden of Disease and Healthcare Resource Use in Patients With Hereditary Transthyretin Amyloidosis in Spain: Findings From the OverTTuRe Global Study
Sep 9, 2025, 16:22 PM -
Describing the Burden of Transthyretin Amyloid Cardiomyopathy (ATTR-CM) on Patients and Their Caregivers: A Real-World Survey in Europe, the United States, and Japan
Sep 9, 2025, 16:22 PM -
Trends in EMA-Approved New Medicines 2015-2024: New Mechanisms of Action and Regulatory Shifts
Sep 9, 2025, 16:22 PM
